We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,073 results
  1. Antiseizure Medications

    Epilepsy and status epilepticus (SE) are both common neurologic disease states encountered in any neurocritical care unit and require aggressive...
    Sulaiman Almohaish, David M. Peters, Gretchen M. Brophy in Principles and Practice of Neurocritical Care
    Chapter 2024
  2. Black-Box Warnings of Antiseizure Medications: What is Inside the Box?

    Antiseizure medications can cause serious adverse reactions and have deleterious drug interactions that often complicate the clinical management of...

    Abdul Wahab, Attiya Iqbal in Pharmaceutical Medicine
    Article 29 April 2023
  3. Neurobehavioral Outcomes of Children with Antenatal Exposure to Antiseizure Medications

    Objectives

    To evaluate the effect of antiepileptic medications prescribed to mothers during pregnancy on the development and behavior of children.

    ...
    Deepa Bhaskaran, Sanjeev Thomas, Liss Maria Scaria in Indian Journal of Pediatrics
    Article 08 June 2024
  4. Growth-related effects of antiseizure medications are of concern in children with epilepsy

    Epilepsy is a common chronic neurological condition in children that is treated with antiseizure medications as first-line (and subsequent-line)...

    Esther S. Kim, Arnold Lee in Drugs & Therapy Perspectives
    Article 26 January 2023
  5. Presynaptic antiseizure medications - basic mechanisms and clues for their rational combinations

    Among clinically highly efficient antiseizure medications (ASMs) there are modifiers of the presynaptic release machinery. Of them, levetiracetam and...

    Ewa K. Czapińska-Ciepiela, Jarogniew Łuszczki, ... Władysław Lasoń in Pharmacological Reports
    Article Open access 22 May 2024
  6. Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis

    Background and Objective

    Drug–drug interactions between direct oral anticoagulants (DOAC) and antiseizure medications via the cytochrome P450 (CYP) or...

    Bonaventure Y. Ip, Ho Ko, ... Thomas W. Leung in CNS Drugs
    Article Open access 24 November 2022
  7. Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC Treatment

    The use of direct oral anticoagulants (DOACs) is increasing because of their superior efficacy and safety compared with vitamin K antagonists....

    Rachel Goldstein, Aviya R. Jacobs, ... Mordechai Muszkat in CNS Drugs
    Article 03 March 2023
  8. Sex Differences in Adverse Effects of Antiseizure Medications in Adults with Epilepsy: A Systematic Review

    Background

    Sex differences in epilepsy have been described in prevalence, seizure propensity and response to treatment. Therefore, taking into account...

    Loretta Giuliano, Vania Durante, ... Barbara Mostacci in CNS Drugs
    Article 30 April 2024
  9. Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database

    Background

    The association between antiseizure medications (ASMs) and suicidality remains controversial. Analyses of additional datasets are needed to...

    Emily E. Leppien, Bennett J. Doughty, ... Kenneth L. McCall in Clinical Drug Investigation
    Article 15 May 2023
  10. Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis

    Objectives

    To compare the efficacy and safety of antiseizure medications (ASMs), both as monotherapies and adjunctive therapies, for idiopathic...

    Hongyuan Chu, **nyu Zhang, ... Xu Yang in Journal of Neurology
    Article Open access 28 June 2023
  11. The Effect of Levetiracetam Compared with Enzyme-Inducing Antiseizure Medications on Apixaban and Rivaroxaban Peak Plasma Concentrations

    Background and Objective

    Post-stroke epilepsy represents an important clinical challenge as it often requires both treatment with direct oral...

    Rachel Goldstein, Natalie Rabkin, ... Mordechai Muszkat in CNS Drugs
    Article Open access 23 March 2024
  12. Efficacy and Safety of Five Broad-Spectrum Antiseizure Medications for Adjunctive Treatment of Refractory Epilepsy: A Systematic Review and Network Meta-analysis

    Background

    Overall, up to one-third of epilepsy patients have drug-resistant epilepsy. However, there was previously no meta-analysis to support the...

    Hecheng Wang, Haoran Wang, ... Yanshuo Han in CNS Drugs
    Article 17 August 2023
  13. Pilot study on the probability of drug-drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective

    Abstract Background

    There is little and controversial information about changes in plasma concentrations (PCs) or clinical events during...

    Federica Ranzato, Roberta Roberti, ... Gianfranco Di Gennaro in Neurological Sciences
    Article Open access 07 August 2023
  14. Anticonvulsant effects of isopimpinellin and its interactions with classic antiseizure medications and borneol in the mouse tonic–clonic seizure model: an isobolographic transformation

    Background

    Overwhelming evidence indicates that some naturally occurring coumarins and terpenes are widely used in folk medicine due to their various...

    Jarogniew J. Łuszczki, Hubert Bojar, ... Krystyna Skalicka-Woźniak in Pharmacological Reports
    Article Open access 11 October 2023
  15. Impact of Antiseizure Medications on Appetite and Weight in Children

    There are numerous potential factors that may affect growth in children with epilepsy, and these must be evaluated in any child with appetite and...

    Ersida Buraniqi, Hicham Dabaja, Elaine C. Wirrell in Pediatric Drugs
    Article 21 May 2022
  16. Imperatorin interacts additively with novel antiseizure medications in the mouse maximal electroshock-induced seizure model: an isobolographic transformation

    Background

    Anticonvulsant effects of imperatorin (IMP) have been experimentally confirmed earlier, but no information is available on the interaction...

    Jarogniew J. Łuszczki, Ewelina Kochman-Moskal, ... Krystyna Skalicka-Woźniak in Pharmacological Reports
    Article Open access 28 November 2023
  17. Efficacy and Tolerability of Adjunctive Brivaracetam in Patients with Focal-Onset Seizures on Specific Concomitant Antiseizure Medications: Pooled Analysis of Double-Blind, Placebo-Controlled Trials

    Introduction

    This article aimed to assess the efficacy and tolerability of adjunctive brivaracetam (BRV) in adults with focal-onset seizures on...

    Brian Moseley, Dimitrios Bourikas, ... Simon Borghs in Advances in Therapy
    Article Open access 15 February 2024
  18. A pilot study on identifying gene signatures as markers for predicting patient response to antiseizure medications

    The majority of the biomarkers were associated with the diagnosis of epilepsy and few of them can be applied to predict the response to antiseizure...

    Yifei Duan, Liyuan Kang, ... Lei Chen in Neurological Sciences
    Article 20 January 2023
Did you find what you were looking for? Share feedback.